全文获取类型
收费全文 | 2984篇 |
免费 | 477篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 69篇 |
妇产科学 | 157篇 |
基础医学 | 307篇 |
口腔科学 | 52篇 |
临床医学 | 847篇 |
内科学 | 619篇 |
皮肤病学 | 27篇 |
神经病学 | 212篇 |
特种医学 | 128篇 |
外科学 | 431篇 |
综合类 | 23篇 |
一般理论 | 2篇 |
预防医学 | 149篇 |
眼科学 | 10篇 |
药学 | 128篇 |
中国医学 | 6篇 |
肿瘤学 | 303篇 |
出版年
2023年 | 14篇 |
2022年 | 31篇 |
2021年 | 62篇 |
2020年 | 24篇 |
2019年 | 48篇 |
2018年 | 94篇 |
2017年 | 125篇 |
2016年 | 139篇 |
2015年 | 140篇 |
2014年 | 141篇 |
2013年 | 192篇 |
2012年 | 153篇 |
2011年 | 178篇 |
2010年 | 127篇 |
2009年 | 135篇 |
2008年 | 156篇 |
2007年 | 152篇 |
2006年 | 144篇 |
2005年 | 133篇 |
2004年 | 134篇 |
2003年 | 104篇 |
2002年 | 76篇 |
2001年 | 74篇 |
2000年 | 76篇 |
1999年 | 63篇 |
1998年 | 29篇 |
1997年 | 33篇 |
1996年 | 44篇 |
1995年 | 29篇 |
1994年 | 25篇 |
1993年 | 25篇 |
1992年 | 66篇 |
1991年 | 61篇 |
1990年 | 47篇 |
1989年 | 42篇 |
1988年 | 44篇 |
1987年 | 38篇 |
1986年 | 34篇 |
1985年 | 36篇 |
1984年 | 23篇 |
1983年 | 20篇 |
1982年 | 23篇 |
1981年 | 9篇 |
1980年 | 9篇 |
1979年 | 21篇 |
1978年 | 13篇 |
1976年 | 13篇 |
1972年 | 12篇 |
1971年 | 13篇 |
1970年 | 14篇 |
排序方式: 共有3483条查询结果,搜索用时 328 毫秒
1.
2.
M Riminucci M T Collins R Lala A Corsi P Matarazzo P Gehron Robey P Bianco 《Molecular pathology》2002,55(1):58-60
In the pituitary gland, activating mutations of the GNAS1 (Gsalpha) gene at Gln227 have been identified in adrenocorticotrophin secreting, growth hormone secreting, and prolactin secreting adenomas. To date, mutations at the codon encoding R201, typically underlying the McCune-Albright syndrome and isolated fibrous dysplasia of bone, have been demonstrated only in growth hormone secreting pituitary adenomas. In this study, a polymerase chain reaction amplified target sequence in exon 8 of the GNAS1 gene was sequenced, identifying the first R201 mutation seen in an isolated basophilic adenoma which generated Cushing's disease in a child. This case adds Cushing's disease to the range of human diseases caused by R201 mutations of the GNAS1 gene. 相似文献
3.
PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells 总被引:65,自引:10,他引:55
PADGEM protein (PADGEM), also known as GMP140, is a platelet alpha- granule membrane protein that is translocated to the external membrane after platelet activation. Although the biosynthesis of this protein was originally thought to be confined to megakaryocytes, the synthesis of PADGEM in endothelial cells was recently demonstrated (McEver et al: Blood 70:1974a, 1987). We now describe the subcellular localization of this protein in endothelial cells. Immunofluorescence staining of permeabilized human umbilical vein endothelial cells with KC4, a well characterized monoclonal antibody to PADGEM, showed positively stained elongated structures similar in distribution and shape to Weibel-Palade bodies. Their identity as Weibel-Palade bodies was confirmed by double label immunofluorescence using KC4 and a polyclonal antiserum to von Willebrand factor (vWf), a protein known to be specifically stored in these organelles. All Weibel-Palade bodies were found to contain PADGEM. In contrast to strong perinuclear staining produced with anti- vWf antibodies, no significant perinuclear staining was obtained with KC4, indicating that relatively little PADGEM is present in the endoplasmic reticulum and in the Golgi apparatus. In endothelial cells treated with secretagogues that stimulate vWf release the elongated structures positive for PADGEM disappeared, further identifying these structures as Weibel-Palade bodies. This observation extends the parallels between Weibel-Palade bodies and alpha-granules and suggests a possible functional association between vWf and PADGEM. 相似文献
4.
Khalil Fattouch Giuseppe Bianco Giuseppe Speziale Roberta Sampognaro Carlo Lavalle Francesco Guccione Pietro Dioguardi Giovanni Ruvolo 《European journal of cardio-thoracic surgery》2007,32(2):326-332
BACKGROUND: The inflammatory cascade has been hypothesized to be an important mechanism of post-ischaemic myocardial reperfusion injury and several studies demonstrated that C1 esterase inhibitor (C1-INH) is effective in post-ischaemia myocardial protection. Therefore, we aimed to investigate prospectively in a randomised double-blind study the cardioprotective effects of C1-INH in ST segment elevation myocardial infarction (STEMI) in patients who underwent emergent reperfusion with coronary artery bypass grafting (CABG). METHODS: In this study, we enrolled 80 patients affected with STEMI who underwent emergent CABG. Patients were assigned in two groups (C1-INH group: receive 1000 UI of C1-INH; and placebo group: receive a saline solution). The effects of C1-INH on complement inhibition, myocardial cell injury extension and clinical outcome were studied. Haemodynamic data and myocardial function were monitored. C1-INH, C3a, C4a complement activation fragments and cardiac troponin I (cTnI) serum levels were measured before, during and after surgery. RESULTS: Patient characteristics were not different between the two groups. The overall in-hospital mortality rate was 6.2%. No statistical significant difference was observed between the two groups with regard to early mortality (p=0.36). Statistical significant difference between the two groups was showed for cardiopulmonary bypass support (p=0.04), administration of high dose of inotropes drugs (p=0.001), time of intubation (p=0.03), intensive care unit (ICU) stay (p=0.04) and in-hospital stay (p=0.03). A significant improvement in mean arterial pressure (p=0.03), cardiac index (p=0.02) and stroke volume (p=0.03) was showed in C1-INH group versus placebo group. The serum cTnI levels were significantly low in the C1-INH group versus placebo group after reperfusion, during the observation period. Plasma levels of C3a and C4a complement fragments were reduced significantly in C1-INH group. No drugs-related adverse effects were observed. CONCLUSIONS: The inhibition of the classic complement pathway by C1-INH appears to be an effective mean of preserving ischaemic myocardium from reperfusion injury as demonstrated by low serum cTnI levels in C1-INH group. Therefore, the use of C1-INH during CABG as a rescue therapy in STEMI patients is probably an effective treatment to inhibit complement activity and to improve cardiac function and haemodynamic performance without impacting early mortality. Large randomised study should be performed to support our results. 相似文献
5.
This column contains the presidential address presented during the Third Annual Meeting of the American Association of Heart Failure Nurses on June 28, 2007, in San Diego, California, titled "Building the Foundation of Excellence in Heart Failure Nursing." 相似文献
6.
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. 总被引:3,自引:0,他引:3
Andrew J Stephenson Peter T Scardino James A Eastham Fernando J Bianco Zohar A Dotan Christopher J DiBlasio Alwyn Reuther Eric A Klein Michael W Kattan 《Journal of clinical oncology》2005,23(28):7005-7012
PURPOSE: A postoperative nomogram for prostate cancer recurrence after radical prostatectomy (RP) has been independently validated as accurate and discriminating. We have updated the nomogram by extending the predictions to 10 years after RP and have enabled the nomogram predictions to be adjusted for the disease-free interval that a patient has maintained after RP. METHODS: Cox regression analysis was used to model the clinical information for 1,881 patients who underwent RP for clinically-localized prostate cancer by two high-volume surgeons. The model was externally validated separately on two independent cohorts of 1,782 patients and 1,357 patients, respectively. Disease progression was defined as a rising prostate-specific antigen (PSA) level, clinical progression, radiotherapy more than 12 months postoperatively, or initiation of systemic therapy. RESULTS: The 10-year progression-free probability for the modeling set was 79% (95% CI, 75% to 82%). Significant variables in the multivariable model included PSA (P = .002), primary (P < .0001) and secondary Gleason grade (P = .0006), extracapsular extension (P < .0001), positive surgical margins (P = .028), seminal vesicle invasion (P < .0001), lymph node involvement (P = .030), treatment year (P = .008), and adjuvant radiotherapy (P = .046). The concordance index of the nomogram when applied to the independent validation sets was 0.81 and 0.79. CONCLUSION: We have developed and validated as a robust predictive model an enhanced postoperative nomogram for prostate cancer recurrence after RP. Unique to predictive models, the nomogram predictions can be adjusted for the disease-free interval that a patient has achieved after RP. 相似文献
7.
8.
9.
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells 总被引:2,自引:0,他引:2
A Budillon P Tagliaferri M Caraglia M R Torrisi N Normanno S Iacobelli G Palmieri M P Stoppelli L Frati A R Bianco 《Cancer research》1991,51(4):1294-1299
Unregulated or increased expression of epidermal growth factor receptor (EGF-R) is a common event in neoplastic transformation; modulation of such a receptor by physiological agents could be, therefore, of clinical interest. We have studied the binding ability, the availability at cell surface, and the synthesis of EGF-R in the A431 and KB human epidermoid cancer cell lines after treatment with recombinant alpha-interferon (IFN-alpha). After 48 h of treatment, IFN-alpha induces, in both cell lines, growth inhibition and enhances class I major histocompatibility HLA complex expression, which is a common marker of IFN action. [125I]EGF total binding assessed after 48 h of treatment with IFN-alpha shows a dose-dependent upregulation of EGF-R binding capacity. Saturation plots of the binding data show that IFN-alpha treatment does not dramatically alter the affinity of the EGF-R and indicate that IFN-alpha only increases the number of low affinity receptors. We show that this effect is due to a specific increase in the synthesis of the receptor protein, as assessed by immunoprecipitation of [35S]methionine-labeled cell extracts. Electron microscopy analysis has confirmed an increase of EGF-R proteins at cell surface without major changes in the morphology of the cells. Taken together, these results indicate that IFN-alpha consistently induces both the binding capacity and the synthesis of EGF-R in human epidermoid cancer cells and suggest the use of such a mechanism for new anticancer therapies. 相似文献
10.